Activities of Cristian TERHEŞ related to 2022/2141(INI)
Plenary speeches (1)
Activities of the European Ombudsman - annual report 2021 (A9-0054/2023 - Anne-Sophie Pelletier)
Amendments (8)
Amendment 11 #
Motion for a resolution
Recital G a (new)
Recital G a (new)
Ga. whereas in 2021 the Ombudsman opened an inquiry on the European Commission’s refusal to give public access to documents concerning the purchase of vaccines against COVID-19 and on the Commission’s failure to deal with the complainant’s access requests within the prescribed time limit;1a _________________ 1a https://www.ombudsman.europa.eu/en/de cision/en/141706
Amendment 12 #
Motion for a resolution
Recital G b (new)
Recital G b (new)
Gb. whereas in 2021 the Ombudsman opened in inquiry on the European Commission's refusal of public access to text messages exchanged between the Commission President and the CEO of a pharmaceutical company on the purchase of a COVID-19 vaccine; 4a _________________ 4a https://www.ombudsman.europa.eu/en/pre ss-release/en/158303
Amendment 13 #
Motion for a resolution
Recital H a (new)
Recital H a (new)
Ha. whereas the Ombudsman has opened an inquiry regarding the European Medicines Agency's (EMA) refusal of public access to documents relating to the manufacturing of mRNA vaccines against COVID-19; 2a _________________ 2a https://www.ombudsman.europa.eu/en/cas e/en/59918
Amendment 27 #
Motion for a resolution
Paragraph 5 a (new)
Paragraph 5 a (new)
5a. Congratulates the Ombudsman for the advice given through the Interactive Guide available on the Ombudsman's website;
Amendment 72 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14a. Welcomes the Ombudsman inquiry regarding the Commission’s refusal to give public access to documents concerning the purchase of vaccines against COVID-19 and the Ombudsman inquiry regarding the European Commission's refusal of public access to text messages exchanged between the Commission President and the CEO of a pharmaceutical company on the purchase of a COVID-19 vaccine;3a _________________ 3a https://www.ombudsman.europa.eu/en/cas e/en/59777
Amendment 73 #
Motion for a resolution
Paragraph 14 b (new)
Paragraph 14 b (new)
14b. Highlights that based on the inquiry, the Ombudsman concluded that the Commission's refusal of public access to text messages exchanged between the Commission President and the CEO of a pharmaceutical company on the purchase of a COVID 19 vaccine (case 1316/2021/MIG) was maladministration; 5a _________________ 5a https://www.ombudsman.europa.eu/en/de cision/en/158295
Amendment 74 #
Motion for a resolution
Paragraph 14 c (new)
Paragraph 14 c (new)
14c. Congratulates the Ombudsman for the inquiry on how the European Commission handled a request for public access to documents concerning the quality of medical masks distributed during the COVID-19 pandemic and highlights that the decision of the Ombudsman on this inquiry was that the Commission's refusal for public access to documents related to the purchase of 1.5 million medical masks that did not meet the required quality standards was maladministration; 7a _________________ 7a https://www.ombudsman.europa.eu/en/de cision/en/158295
Amendment 78 #
Motion for a resolution
Paragraph 16 a (new)
Paragraph 16 a (new)
16a. Congratulates the Ombudsman for the continued focus on how the EU administration deals with so-called "revolving doors" and for opening a broad strategic inquiry into how the Commission handles revolving door situations; 6a _________________ 6a https://www.ombudsman.europa.eu/en/do c/annual-report/en/156017